Internal and Emergency Medicine

, Volume 9, Issue 2, pp 161–164 | Cite as

Relationship between previous treatments and onset of symptoms in patients with Whipple’s disease

  • Lucia Trotta
  • Federico Biagi
  • Michele Di Stefano
  • Gino Roberto Corazza
IM - ORIGINAL

Abstract

The clinical features of Whipple’s disease (WD) consist of arthropathy that precedes the involvement of other organs, such as the gastrointestinal tract, nervous system and heart. It has been shown that gastrointestinal manifestations can be precipitated by immunosuppressive therapy used to control the arthropathy. In the present study, we investigated the clinical features of the Italian population of patients affected by WD. The clinical histories of 22 patients with WD were reviewed. Relationship between previous treatments and onset of symptoms was analysed. 20/22 patients suffered from arthropathy that had started before gastrointestinal complaints; gastrointestinal symptoms were present in 18 patients and neurological involvement was found in 5. WD must always be taken into account in male patients with long-standing ill-defined arthropathy, and it should be ruled out before starting immunosuppressive or antibiotic treatment that can make correct diagnosis and management very difficult.

Keywords

Whipple’s disease Tropheryma whipplei Immunosuppressive therapy Small bowel 

References

  1. 1.
    Fennolar F, Puechal X, Raoult D (2007) Whipple’s disease. N Engl J Med 356:55–66CrossRefGoogle Scholar
  2. 2.
    Schneider T, Moos V, Loddenkemper C, Marth T, Fenollar F, Raoult D (2008) Whipple’s disease: new aspects of pathogenesis and treatment. Lancet Infect Dis 8:179–190PubMedCrossRefGoogle Scholar
  3. 3.
    Relman DA, Schmidt TM, MacDermott RP, Falkow S (1992) Identification of the uncultured bacillus of Whipple’s disease. N Engl J Med 327:293–301PubMedCrossRefGoogle Scholar
  4. 4.
    Raoult D, Birg ML, La Scola B, Fournier PE, Enea M, Lepidi H, Roux V, Piette JC, Vandenesch F, Vital-Durand D, Marrie TJ (2000) Cultivation of the bacillus of Whipple’s disease. N Engl J Med 342:620–625PubMedCrossRefGoogle Scholar
  5. 5.
    Schöniger-Hekele M, Petermann D, Weber B, Müller C (2007) Tropheryma whipplei in the environment: survey of sewage plant influxes and sewage plant workers. Appl Environ Microbiol 73:2033–2035PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Lagier JC, Fenollar F, Lepidi H, Raoult D (2011) Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple’s disease. J Antimicrob Chemother 66:1188–1189PubMedCrossRefGoogle Scholar
  7. 7.
    Li W, Fennolar F, Rolain J-M, Fournier P-E, Feurle GE, Müller C, Moos V, Marth T, Altwegg M, Calligaris-Maibach RC, Schneider T, Biagi F, La Scola B, Raoult D (2008) Genotyping reveals a wide heterogeneity of Tropheryma whipplei. Microbiology 154:521–527PubMedCrossRefGoogle Scholar
  8. 8.
    Martinetti M, Biagi F, Badulli C, Feurle GE, Müller C, Moos V, Schneider T, Marth T, Marchese A, Trotta L, Sachetto S, Pasi A, De Silvestri A, Salvaneschi L, Corazza GR (2009) The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple’s disease. Gastroenterology 136:2289–2294PubMedCrossRefGoogle Scholar
  9. 9.
    Marth T, Kleen N, Stallmach A, Ring S, Aziz S, Schmidt C, Strober W, Zeitz M, Schneider T (2002) Dysregulated peripheral and mucosal Th1/Th2 response in Whipple’s disease. Gastroenterology 123:1468–1477PubMedCrossRefGoogle Scholar
  10. 10.
    Fennolar F, Raoult D (2001) Whipple’s disease. Clin Diagn Lab Immunol 8:1–8Google Scholar
  11. 11.
    Dutly F, Altwegg M (2001) Whipple’s disease and “Tropheryma whippelii”. Clin Microbiol Rev 14:561–583PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Di Stefano M, Jorizzo RA, Brusco G, Cecchetti L, Sciarra G, Loperfido S, Brandi G, Gasbarrini G, Corazza GR (1998) Bone mass and metabolism in Whipple’s disease: the role of hypogonadism. Scand J Gastroenterol 33:1180–1185PubMedCrossRefGoogle Scholar
  13. 13.
    Raoult D, La Scola B, Lecocq P, Lepidi H, Fournier PE (2001) Culture and immunological detection of Tropheryma whippelii from the duodenum of a patient with Whipple disease. JAMA 285:1039–1043PubMedCrossRefGoogle Scholar
  14. 14.
    Feurle GE, Junga NS, Marth T (2010) Efficacy of ceftriaxone or meropenem as initial therapies in Whipple’s disease. Gastroenterology 138:478–486PubMedCrossRefGoogle Scholar
  15. 15.
    Lagier JC, Fenollar F, Lepidi H, Raoult D (2011) Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple’s disease. J Antimicrob Chemother 66:1188–1189PubMedCrossRefGoogle Scholar
  16. 16.
    Mahnel R, Kalt A, Ring S, Stallmach A, Strober W, Marth T (2005) Immunosuppressive therapy in Whipple’s disease patients is associated with the appearance of gastrointestinal manifestations. Am J Gastroenterol 100:1167–1173PubMedCrossRefGoogle Scholar
  17. 17.
    Feurle GE, Moos V, Schinnerling K, Geelhaar A, Allers K, Biagi F, Bläker H, Moter A, Loddenkemper C, Jansen A, Schneider T (2010) The immune reconstitution inflammatory syndrome in Whipple disease. A cohort study. Ann Intern Med 153:710–717PubMedCrossRefGoogle Scholar
  18. 18.
    Lamparter S, Dittrich C, Koehler HH (2008) Exacerbation of WD by immunosuppressants. J Clin Gastroenterol 42:760–761PubMedCrossRefGoogle Scholar
  19. 19.
    Kneitz C, Suerbaum S, Beer M, Müller J, Jahns R, Tony HP (2005) Exacerbation of Whipple’s disease associated with infliximab treatment. Scand J Rheumatol 34:148–151PubMedCrossRefGoogle Scholar
  20. 20.
    Hoppè E, Masson C, Audran M, Drillon M, Andreu M, Saraux A, Berthelot JM, Maugars Y, Hmamouchi I, Morel J (2010) Whipple’s disease diagnosed during biological treatment for joint disease. Joint Bone Spine 77:335–339PubMedCrossRefGoogle Scholar
  21. 21.
    Corazza GR, Brusco G, Andreani ML, Biagi F, Di Stefano M, Gasbarrini G (1996) Previous misdiagnosis and diagnostic delay in adult celiac sprue. J Clin Gastroenterol 22:324–325PubMedCrossRefGoogle Scholar

Copyright information

© SIMI 2012

Authors and Affiliations

  • Lucia Trotta
    • 1
  • Federico Biagi
    • 1
  • Michele Di Stefano
    • 1
  • Gino Roberto Corazza
    • 1
  1. 1.First Department of Internal Medicine, Coeliac Centre, Fondazione IRCCS Policlinico San MatteoUniversity of PaviaPaviaItaly

Personalised recommendations